Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Lymphoid 2Gynecologic 2Gastrointestinal 2Breast 2Thoracic 1Plasma cell 1Other 1Head & Neck 1

Conditions

Head and Neck Neoplasms 1Agnosia 1

Interventions

Cisplatin 416Radiotherapy 240Radiotherapy, Intensity-Modulated 178Cetuximab 177Docetaxel 166pembrolizumab 148Carboplatin 121Fluorouracil 113Paclitaxel 90Nivolumab 82Gemcitabine 82Radiation 72Surveys and Questionnaires 71Drug Therapy 70toripalimab 68Surgical Procedures, Operative 64Magnetic Resonance Spectroscopy 63Capecitabine 50Blood Specimen Collection 50Chemoradiotherapy 46Biopsy 44camrelizumab 41durvalumab 40Radiosurgery 40Standard of Care 38Erlotinib Hydrochloride 34nimotuzumab 32130-nm albumin-bound paclitaxel 32tislelizumab 31apatinib 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ketorolac Tromethamine × Head & Neck × Clear all
NCT04246697 2023-08-18

Multimodal Pain Study in Free Flap Patients

University of Kansas Medical Center

Phase 4 Completed
30 enrolled
Head & Neck

Agnosia, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡